Associated Press NEW YORK — Pfizer said Monday it will buy NextWave Pharmaceuticals Inc., a company that makes a liquid attention deficit hyperactivity disorder drug, in a deal worth as much as $700 million. The Food and Drug Administration approved NextWave's drug Quillivant XR in September, and the once-per-day drug is expected to be in [...]
October 2012 Compounding the Issue The Art and Science of Concocting Pharmaceutical Solutions By ELIZABETH TARAS Amy Barden has what many would consider a unique job. As a certified pharmacy technician at Louis & Clark pharmacy on Birnie Ave. in Springfield, she’s also certified in basic, sterile, and veterinary compounding. "When people ask what I [...]
By Andis Robeznieks Posted: October 18, 2012 - 11:15 am ET The American Medical Association has named New England Journal of Medicine Publisher and Managing Director Thomas Easley as its new senior vice president of periodic publications, which puts him in charge of the Journal of the American Medical Association, the JAMA Network of medical [...]
(Reuters) - St. Jude Medical Inc warned Wall Street that U.S. health regulators might issue a warning letter about one of its factories in California as it reported another weak quarterly performance and reeled in its outlook. St. Jude shares fell 6.1 percent to $40.30 in afternoon trading on the New York Stock Exchange. During [...]
NEW YORK (Reuters Health) - Record-keeping for a patient complication used by Medicare to determine how much hospitals get reimbursed is not comprehensive or accurate, undermining the policy's value, a new study suggests. In an effort to get more for their money, the Centers for Medicare & Medicaid Services (CMS) - as well as some [...]
A British woman paralyzed from the chest down by a horse riding accident has become the first person to take home a robotic exoskeleton that enables her to walk. Although bionic exoskeletons have been used in hospitals and rehabilitation centers, Claire Lomas is the first to take the ReWalk suit home for everyday use. Lomas [...]
(Reuters) - Valeant Pharmaceuticals International Inc's stock jumped 15 percent on Tuesday on news of a $2.6 billion deal to buy Medicis Pharmaceutical Corp, a move that could give the Canadian drugmaker's skin care business a big boost. Valeant announced the $44 a share offer for its U.S. competitor on Monday, when markets were closed [...]